Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Florida Melanoma Trial
NCT00005615Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Jul 1997
- Primary completion
- Dec 2005
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa in melanoma, sponsored by Moffitt Cancer Center. Primary endpoint: Overall Response Rate at 7 years. Started Jul 1997; status: completed.
02
Drugs
interferon alfa
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00005615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005615.